Cathy Yuen
  1. Associate

Ms. Yuen is an associate in Davis Polk’s Corporate Department, resident in Hong Kong. 

Work Highlights

  • RemeGen's $514.3 million Hong Kong IPO and global offering
  • JW Therapeutics' $300 million Hong Kong IPO and global offering
  • Ocumension Therapeutics' $200.4 million HKIPO and global offering
  • Shenzhen Hepalink Pharmaceutical's $523 million HKIPO and global offering

Professional History

  • Davis Polk since 2019

Practice Focus

Bar Admissions

  • Hong Kong

Education

  • B.A., Law, University of Cambridge, 2014
  • PCLL, City University of Hong Kong, 2015

Languages

  • Cantonese
  • Mandarin